Unknown

Dataset Information

0

Arginine Metabolism Is Altered in Adults with A-? + Ketosis-Prone Diabetes.


ABSTRACT: Background:A-? + ketosis-prone diabetes (KPD) is a subset of type 2 diabetes in which patients have severe but reversible ? cell dysfunction of unknown etiology. Plasma metabolomic analysis indicates that abnormal arginine metabolism may be involved. Objective:The objective of this study was to determine the relation between gut microbiome and arginine metabolism and the relation between arginine availability and ? cell function in KPD patients compared with control participants. Methods:Kinetics of arginine and related metabolites were measured with stable isotope tracers, and insulin secretory responses to arginine and glucose were determined under euglycemic and hyperglycemic conditions in 6 KPD patients and 6 age-, gender-, and body mass index-matched control participants. Glucose potentiation of arginine-induced insulin secretion was performed in a different set of 6 KPD and 3 control participants. Results:Arginine availability was higher in KPD patients during euglycemia [53.5 ± 4.3 (mean ± SEM) compared with 40.3 ± 2.4 ?mol · kg lean body mass (LBM)-1 · h-1, P = 0.03] but declined more in response to hyperglycemia (? 10.15 ± 2.6 compared with ? 3.20 ± 1.3 ?mol · kg LBM-1 · h-1, P = 0.041). During hyperglycemia, ornithine flux was not different between groups but after an arginine bolus, plasma ornithine AUC trended higher in KPD patients (3360 ± 294 compared with 2584 ± 259 min · ?mol · L-1, P = 0.08). In both euglycemia and hyperglycemia, the first-phase insulin responses to glucose stimulation were lower in KPD patients (euglycemic insulin AUC 282 ± 108 compared with 926 ± 257 min · ?U · mL-1, P = 0.02; hyperglycemic insulin AUC 358 ± 79 compared with 866 ± 292 min · ?U · mL-1, P = 0.05), but exogenous arginine restored first-phase insulin secretion in KPD patients to the level of control participants. Conclusion:Compared with control participants, KPD patients have increased arginine availability in the euglycemic state, indicating a higher requirement. This is compromised during hyperglycemia, with an inadequate supply of arginine to sustain metabolic functions such as insulin secretion. Exogenous arginine administration restores a normal insulin secretory response.

SUBMITTER: Mulukutla SN 

PROVIDER: S-EPMC6251649 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Background</h4>A-β + ketosis-prone diabetes (KPD) is a subset of type 2 diabetes in which patients have severe but reversible β cell dysfunction of unknown etiology. Plasma metabolomic analysis indicates that abnormal arginine metabolism may be involved.<h4>Objective</h4>The objective of this study was to determine the relation between gut microbiome and arginine metabolism and the relation between arginine availability and β cell function in KPD patients compared with control participants.<  ...[more]

Similar Datasets

| S-EPMC2528854 | biostudies-literature
| S-EPMC7078091 | biostudies-literature
| S-EPMC3351851 | biostudies-literature
| S-EPMC5022089 | biostudies-literature
2021-06-01 | GSE165385 | GEO
| S-EPMC2671096 | biostudies-literature
| S-EPMC8576504 | biostudies-literature
| S-EPMC10667908 | biostudies-literature
| S-EPMC10565480 | biostudies-literature
| S-EPMC6245211 | biostudies-literature